Significance Statement {#s1}
======================

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic voiding disorder with symptoms that include urinary urgency, urinary frequency, and pain in the bladder and surrounding pelvic region, in the absence of proven urinary infection or other noticeable pathology. Although the exact cause of this disorder is unknown, numerous lines of evidence suggest that changes in the permeability of the epithelial cell layer that cover the internal surface of the urinary bladder contribute to the perpetuation of the symptoms. The present study examines the mechanisms that mediate lower urinary tract symptoms and pain in an animal model with reduced urothelial barrier function.

Introduction {#s2}
============

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic voiding disorder that presents with pain in the bladder and surrounding pelvic region ([@B73]; [@B71]; [@B44]; [@B72]; [@B10]). While the cause of IC/BPS is unknown, several lines of evidence indicate that increased urothelial permeability to urine constituents plays an important role in the pathophysiology of this disease ([@B79]; [@B16]; [@B41]; [@B77]). The internal surface of the urinary bladder is lined by the urothelium, a stratified epithelium that restricts the passage of ions and metabolic products from the urine into the bladder interstitium ([@B54]). Because bladder afferent terminals reside within the urothelium and in a subepithelial plexus very close to the basal surface of the epithelium ([@B37]), changes in the permeability of the urothelial barrier to urinary constituents can alter sensory input and elicit painful sensations. Consistent with the presence of increased bladder afferent input, IC/BPS patients present pain that augments with bladder filling and is relieved by bladder emptying ([@B73]; [@B71]; [@B44]; [@B72]).

The urinary bladder is innervated by the pelvic and hypogastric nerves, which convey information about the filling status and noxious stimuli to the CNS ([@B28]). These nerves consist of small myelinated Aδ fibers that respond to passive distension of the bladder wall and active contraction, carrying information about bladder filling, and unmyelinated C fibers with high mechanical threshold that respond to noxious chemical stimulation of the bladder mucosa ([@B28]). A population of fibers with a conduction speed of C afferents that responds to bladder distension in the physiologic range has also been described ([@B34]; [@B4]; [@B86]; [@B96]; [@B33]). While strong evidence indicates that afferent sensitization contributes to voiding dysfunction and pain in IC/BPS ([@B24]; [@B40]; [@B106]; [@B75]), the type of afferents affected and the molecular mechanism of sensitization remain largely unknown.

Although the urothelium is multilayered, it is the outermost umbrella cell layer that forms a multifactorial barrier that includes a mucin layer with anti-adherence properties, an apical membrane with inherently low permeability to urea and water, and relatively impermeable tight junctions (TJs; [@B54]). There is a strong and growing body of evidence showing changes in the expression of TJ-associated proteins in biopsies from patients with IC/BPS ([@B88]; [@B45]; [@B84]; [@B59]; [@B46]). TJs consist of a network of cytosolic and membrane proteins that associate to seal the paracellular space between adjacent epithelial cells just beneath their apical surface. Claudins (Cldns), a family of tetra-membrane spanning proteins, form the structural and functional core of the TJs and thus define the electrical properties of epithelia. Recently, an extensive analysis of gene expression reported a ninety-fold upregulation of Cldn2 mRNA levels in biopsies of patients with IC/BPS, when compared with controls ([@B84]). In support of the notion that Cldn2 upregulation contributes to IC/BPS symptoms, we recently showed that the overexpression of Cldn2 in the umbrella cell layer increases the permeability of the urothelium to small ions, triggers an inflammatory process in the bladder mucosa and lamina propria, and increases voiding frequency ([@B70]).

The present work examines the consequences of Cldn2 overexpression in the urothelium on somatic sensitivity in the pelvic area and bladder afferent firing. The results of our studies indicate that Cldn2 upregulation reduces pelvic mechanical threshold by sensitizing primarily bladders afferents of Aδ origin.

Materials and Methods {#s3}
=====================

Reagents and antibodies {#s3A}
-----------------------

All chemicals were purchased from Sigma-Aldrich, unless otherwise specified. Mouse monoclonal antibody to Cldn2 was purchased from Invitrogen, mouse monoclonal antibody to β-actin was from Sigma and rabbit polyclonal to c-Fos was from EnCor Biotechnology. Monoclonal mouse to phospho-p44/42 MAPK (pERK1/2) (Thr202/Tyr204) antibody and rabbit p44/42 MAPK (ERK1/2) antibody were purchased from Cell Signaling Technology. Cy3-coupled, FITC-coupled, biotinylated donkey anti-rabbit IgG, and horseradish peroxidase-coupled secondary antibodies were purchased from Jackson ImmunoResearch. Phalloidin Rhodamine- and Phalloidin Alexa Fluor 647-conjugated were purchased from Invitrogen.

Animals {#s3B}
-------

All experimental procedures were approved by the University of Pittsburgh Institutional Animal Care and Use Committee. Female Sprague Dawley rats (250--300 g; Envigo) were used throughout. Rats were housed under a 12/12 h light/dark cycle with free access to food and water. Animals were randomized to blinded treatment and control groups. The stage of the estrous cycle was not monitored. Animals were euthanized by CO~2~ inhalation, followed by a thoracotomy.

Preparation of recombinant adenoviruses and *in situ* transduction of umbrella cells {#s3C}
------------------------------------------------------------------------------------

Replication-defective adenoviruses coding for GFP (AdGFP) or Cldn2 (AdCldn2) were constructed by subcloning the coding region of the respective proteins into the plasmid pAdlox as previously described ([@B70]). Adenoviruses were generated at the University of Pittsburgh Vector Core facility. *In situ* transduction of umbrella cells was accomplished via intravesical instillation of adenoviruses under isoflurane anesthesia ([@B55]; [@B70]). Briefly, a day before physiologic studies were conducted a 22-gauge Teflon catheter (Smiths Medical) was inserted in the urethra to drain the urine and wash the urinary bladder. After three consecutive washes with 450 μl of Dulbecco's PBS buffer (DPBS), the bladder was infused with 450 μl of 0.1% (w/v) n-Dodecyl-β-D-maltoside dissolved in DPBS. The catheter was removed immediately after, and the urethral orifice was clamped with a metal clip to prevent leakage. The metal clip was applied to the skin and musculature surrounding the urethra. After 5 min, the catheter was reintroduced through the urethra and the bladder was emptied. The urinary bladder was infused thereafter with 450 μl of DPBS containing 2 × 10^10^ infectious virus particles of AdGFP or AdCldn2 and the external urethral orifice was clamped again. After a 30 min incubation, the catheter was reintroduced through the urethra and the bladder was emptied and washed one time with DPBS. Then, rats were allowed to recover from anesthesia. No signs of pain due to urethral clamping (i.e., licking or scratching of the pelvic area) were apparent in the transduced animals. Experiments were performed 24 h after adenoviral transduction, unless otherwise indicated.

Immunofluorescent labeling and image capture {#s3D}
--------------------------------------------

Urinary bladders, urethras and dorsal root ganglia (DRGs) harvested from rats transduced with AdGFP or AdCldn2 were processed as previously described ([@B70]). Briefly, urinary bladders and urethras were carefully cut open and pinned mucosal side up onto a rubber sheet submerged in Krebs solution containing 110 mM NaCl, 25 mM NaHCO~3~, 5.8 mM KCl, 1.2 mM MgSO~4~, 1.2 mM KH~2~PO~4~, 2 mM CaCl~2~, and 11 mM glucose buffered at pH 7.4 by gassing with a mixture of 95% O~2~/5% CO~2~ (v/v) at 37°C. Bladders, urethras and DRGs were fixed with 4% (v/v) paraformaldehyde in Krebs buffer for 30 min at 37°C. Fixed tissues were incubated in 30% (w/v) sucrose dissolved in PBS at 4°C until the tissue lost its buoyancy and sank to the bottom of the tube. Bladders and urethras were embedded in optimal cutting temperature (O.C.T.) compound. Fixed DRGs were embedded in a 50/50 mixture of O.C.T. and sucrose (30% w/v in PBS), before storage at −80°C. Frozen tissue blocks were sectioned with CM1950 cryostat (Leica). Bladder sections were labeled with primary antibodies or fluorophore-labeled probes as previously described ([@B70]). Confocal images from bladder and urethra sections were captured using a Leica TCS SP5 CW-STED confocal microscope (in normal confocal mode) equipped with a PL Apo 20× air (N.A. = 0.7) or a PL Apo 63× glycerol objective (N.A. = 1.3) and low-noise hybrid detectors. Images from fixed DRGs were captured with a Leica DM6000B upright microscope (fitted with a 40× HCX PL-APO, 1.25 N.A., objective) equipped with a QImaging Retiga 4000R color digital camera interfaced with an Apple iMac computer running Volocity Acquisition software (version 6.3). The captured confocal images were contrast corrected using Volocity (PerkinElmer) or ImageJ (NIH) and then assembled in Adobe Illustrator.

Measurements of urinary bladder electrical resistance {#s3E}
-----------------------------------------------------

Urinary bladders harvested from transduced animals were mounted on custom fabricated Teflon tissue sliders with an exposed tissue area of 0.65 cm^2^ and eight sharp pins set at 3 mm from the opening, as previously described ([@B70]). Silicone grease (Dow Corning) was carefully applied to the region of tissue impaled by the pins to prevent edge damage. Tissue sliders were inserted into the chambers of an EM-CSYS Ussing system (Physiologic Instruments) equipped with a heating block for temperature control. The mucosal and serosal hemichambers were filled with 3 and 5 ml of Krebs solution, respectively. The hemichambers were continuously bubbled with 95% O~2~/5% CO~2~ (v/v) and the temperature inside was kept at 37°C. The mucosal and serosal hemichambers were connected to Ag/AgCl electrodes via 5 M NaCl agar bridges for voltage sensing and current passing. These electrodes were connected to a VCC MC6 Multichannel Voltage/Current Clamp (Physiologic Instruments). Signals were low-pass filtered at 1 kHz (four-pole Bessel filter) and digitized with a Digidata 1440A interface at 5 kHz (Molecular Devices). Command protocols and data acquisition were controlled by pClamp 10 (Molecular Devices). Liquid junction potentials were compensated using an offset-removal circuit before tissue mounting. Current/voltage (I/V) relationships were generated by applying 1 μA current steps from −5 to + 5 μA with a duration of 400 ms. Tissue electrical resistance (TER) was calculated from the slope of the curve.

Tissue edema quantification {#s3F}
---------------------------

To measure bladder edema, the percentage of tissue water content of bladders transduced with AdGFP or AdCldn2 was estimated ([@B14]). Urinary bladders were harvested through an abdominal incision, carefully dried with a Kimwipe paper to eliminate the urine and weighed to obtain the wet mass. To determine the dry mass, samples were desiccated to constant weight at 55°C. The percentage of water tissue content was calculated as,$$\frac{WM - DM}{WM} \times 100$$

Assessment of mechanical allodynia {#s3G}
----------------------------------

Thresholds to mechanical stimuli applied to the pelvic area and hind paw were estimated with von Frey filaments (Touch Test Sensory Evaluators, North Coast Medical) using the up-down method described by Chaplan and colleagues ([@B17]). Rats were individually placed in modular cages (Bioseb) on an elevated wire-mesh platform to allow access to the pelvic area and plantar surface of hind paws. The animals were acclimatized for at least 1h before the test. The stimulus was applied on the plantar surface of a hind paw and on the lower abdominal area close to the urinary bladder. von Frey filaments were applied to the tested area for 1--3 s with intervals between stimuli of 15 s. Testing in the pelvic area was initiated with a von Frey filament with a calibrated force of 1 g. Testing in the hind paw was initiated with a von Frey filament with a calibrated force of 10 g. When a negative response was observed, the next-stronger filament was applied. When a positive response was observed, the next-weaker stimulus was applied. Abdominal withdrawal (either contraction of the abdominal musculature or postural retraction of the abdomen), licking or scratching in the pelvic area in response to von Frey filament application were considered a positive response. When stimuli were applied to the plantar surface, a response was considered positive when the animal withdrew the paw sharply or licked the tested limb. After the response threshold was first crossed, four additional filaments were applied that varied sequentially up or down based on the animal response. The resulting pattern of positive and negative responses was tabulated and the 50% response threshold was calculated using the equation:$$\text{50\%\ threshold\ (g)} = \frac{10^{\lbrack{X_{f} + k\delta}\rbrack}}{10,000}$$where X~f~ represents the value of the final von Frey filament used, *k* represents the tabular value for the pattern of positive/negative responses ([@B31]; [@B17]), and *δ* represents the mean difference (in log units) between stimuli.

Measurement of fecal pellet output {#s3H}
----------------------------------

One day after transduction, rats were placed individually in plastic cages (W, 375 mm × D, 480 mm × H, 210 mm) with free access to food and water. After a 4-h period, rats were removed, the bedding was carefully inspected, and the number of fecal pellets produced during this period was counted.

Western blot analysis {#s3I}
---------------------

Urinary bladders harvested from control and rats transduced with AdCldn2 were pinned in a square grid holder pad. Urothelial samples were obtained by gently scraping the epithelium into RIPA buffer \[40 mM Tris, 150 mM NaCl, 2 mM EDTA, 10% (v/v) glycerol, 1% (v/v Triton X−100, 0.5% (w/v) sodium deoxycholate, 0.2% (w/v) SDS, and a Protease Inhibitor Cocktail Set III (EMD Bioscience); pH 7.6\]. Extracts were rotated at 2000 rpm for 20 min at 4°C and then centrifuged at 25,000 × *g* for 20 min at 4°C. The supernatant was collected and placed in a −20°C freezer until further use. Spinal cord segments receiving bladder input \[lumbosacral (LS; L6-S1) and thoracolumbar (TL; T13-L2)\] were harvested from rats transduced with AdGFP or AdCldn2. Tissue was homogenized in RIPA buffer supplemented with protease inhibitor cocktail set III (EMD Bioscience) and phosphatase inhibitor cocktail (Cell Signaling Technology) in a disperser device (Polytron PT 10−35 GT, Kinematica) at 4°C. The homogenate was centrifuged at 25,000 × *g* for 20 min at 4°C. The supernatant was collected in a new tube and kept on ice for Western blot analysis. Protein concentration in the samples was determined with BCA Protein Assay (Thermo Fisher Scientific). Urothelial samples were mixed in a 1:1 ratio with loading buffer (Laemmli sample buffer supplemented with 0.277 M SDS and 1.420 M β-mercaptoethanol) and then incubated for 45 min at 37°C. Spinal cord samples were mixed in a 1:1 ratio with Laemmli sample loading buffer and heated at 95°C minutes for 5 min. Protein samples were loaded onto Criterion TGX 12% gels (Bio-Rad) and resolved by electrophoresis at 180 V for 50 min. Proteins were transferred to nitrocellulose membranes using a Trans-Blot Turbo Transfer system (Bio-Rad) according to the manufacturer's instructions. Membranes were blocked with PBS supplemented with 10% (w/v) nonfat milk for 1 h. After blocking, membranes were incubated with a Cldn2 (1:5000), β-actin (1:5000), ERK (1:1000), or a pERK (1:2000) primary antibody overnight at 4°C. The next day, membranes were incubated with the corresponding secondary antibodies conjugated with peroxidase (1:5000; KPL). Bands were visualized using Western Lightning Chemiluminescence Reagent Plus (PerkinElmer) and quantified with ImageJ.

c-Fos immunostaining in spinal cord segments {#s3J}
--------------------------------------------

Rats were anesthetized with isoflurane (2--4% in O~2~) and urethane (1.2 g/kg; Sigma). For acetic acid positive controls, urinary bladders were catheterized through the dome using a flared PE50 catheter connected to an infusion pump. Acetic acid (1% in saline) was infused for 2 h at a rate of 0.1 ml/min, after which the rats were perfused through the heart with PBS and 4% (v/v) paraformaldehyde in PBS. Anesthetized rats transduced with AdGFP and AdCldn2 were perfused through the heart with PBS and then with by 4% (v/v) paraformaldehyde in PBS. Spinal cord segments (L4, L6-S1, T13-L2, and C4) were collected, post-fixed for ∼2 h in 4% (v/v) paraformaldehyde, and immersed in 20% sucrose in PBS for ∼24 h and then in 30% sucrose in PBS for 24--48 h. Tissue was embedded in a 50/50 mixture of O.C.T. and sucrose (30% w/v in PBS) and stored at −80°C. Frozen tissue blocks were sectioned using a CM1950 cryostat (Leica); 35-μm sections were immediately placed in 0.1 M sodium phosphate buffer, pH 7.2 (free floating sections). To block endogenous peroxidase activity, sections were treated with 0.15% (w/v) H~2~O~2~ in sodium phosphate buffer. After several rinses with sodium phosphate buffer, sections were incubated overnight with a rabbit antibody to c-Fos (1:5000; EnCor Biotechnology) in blocking buffer (sodium phosphate buffer supplemented with 1% BSA, 1% normal donkey serum and 0.3% Triton X-100). Sections were rinsed in sodium phosphate buffer and then incubated with a biotinylated donkey antibody to rabbit IgG (1:500) in blocking buffer for 1 h at room temperature. After additional rinses, the tissue was incubated in Avidin-Biotin Complex (VectaStain Elite Reagents, Vector Labs) in blocking buffer for 1.5 h at room temperature. After several rinses with sodium phosphate buffer, the tissue was treated with 0.1 M sodium acetate buffer, pH 4, for 10 min. For staining, sections were immersed in filtered diaminobenzadine solution containing 2.5% (w/v) NiSO~4~ and 0.003 % (w/v) H~2~O~2~ in sodium acetate buffer as previously described ([@B66]; [@B81]). To stop the peroxidase catalyzed reaction, tissue was placed in 0.1 M sodium acetate buffer. After several washes in sodium phosphate buffer, sections were mounted onto charged glass microscopic slides (Superfrost Plus; Thermo Fisher Scientific) and left at room temperature overnight to dry. Tissue was dehydrated in a graded ethanol series and defatted in xylene. Slides were coverslipped using Cytoseal 60 (Thermo Fisher Scientific). Tile scanning of spinal cord sections was performed with a Leica TCS SP8 confocal microscope equipped with a 20× (Dry; N.A. = 0.75) objective, resonant scanner, and 638 laser line to generate transmitted light stacks with 10 μm step size. Automated merging was achieved with LASX acquisition software using smooth overlap blending. The absolute number of c-Fos-positive cells in spinal cord sections was quantified with ImageJ 1.51k (NIH) using the multi-point tool. For each spinal cord segment, the mean number of c-Fos-positive cells was estimated from three randomly selected spinal cord sections.

Retrograde labeling of bladder sensory neurons {#s3K}
----------------------------------------------

Bladder afferent neurons were labeled with the fluorescent dye DiI (1,1\'-dioctadecyl-3,3,3\',3\'-Tetramethylindocarbocyanine perchlorate, Invitrogen) as reported in the literature ([@B103]; [@B101]; [@B105]; [@B25]; [@B27]). Briefly, rats were anesthetized with isoflurane and the bladder was exposed through an abdominal incision (∼1 cm in length). Dil (5% w/v in DMSO) was injected at four to six sites (total volume, 20--30 μl) in the bladder wall with a syringe. At each injection site, the needle was kept in place for 20--30 s after inoculation. Any visible leakage of dye was removed by application of a cotton swab and rinsed with saline. The muscle layer and skin incision were individually closed with 5.0 and 3.0 silk sutures (AD Surgical), respectively. Postoperative analgesia was provided by subcutaneous administration of ketoprofen (5 mg/kg, Zoetis). Ampicillin (10 mg/kg, Boehringer Ingelheim Vetmedica) was administrated to prevent infections. Rats were housed under the conditions described above between 8 and 12 d before any further procedure was performed.

Isolation of bladder sensory neurons {#s3L}
------------------------------------

Pelvic and hypogastric nerve bladder afferents have cell bodies located in LS L6-S2 and TL T13-L2 DRG, respectively. To isolate bladder sensory neurons, L6-S2 or T13-L2 DRGs were harvested and transfered to a cell culture dish containing neurobasal media (Neuro-A medium supplemented with 5% of B27 supplements, 0.5 mM L-glutamine, and 10 U/ml of penicillin/streptomycin mixture, Invitrogen). DRGs were minced and agitated in a cell culture flask containing 5 ml of neurobasal media supplemented with 10 mg of collagenase type 4 (Worthington Biochemical) and 5 mg of trypsin (Worthington Biochemical) for 30 min at 37°C. Tissue fragments were gently triturated with a fire-polished glass pipette and the cell suspension was centrifuged at 420 × *g* for 5 min. The pellet, containing DRG somas, was resuspended in neurobasal media. The centrifugation and resuspension steps were repeated three times. Finally, the pellet was resuspended in 1.5 ml of neurobasal media, and the suspension was plated on coverslips coated with ornithine and laminin inside a six-well tissue culture plate. After an incubation of 2 h at 37°C with 5% CO~2~, 3 ml of warm neurobasal media was added to each well and the tissue culture plate was returned to the incubator. Electrophysiological studies were performed within 2 and 10 h of plating.

Patch-clamp studies {#s3M}
-------------------

Whole-cell patch-clamp recordings from acutely dissociated bladder sensory neurons were obtained with the perforated patch technique using Amphotericin B. Current-clamp recordings were performed at room temperature with a PC-505B patch-clamp amplifier (Warner Instruments). Glass coverslips with DRG neurons were transferred to a chamber mounted on the stage of a Nikon Ti inverted microscope equipped a Sedat Quad set (Chroma Technology), a PhotoFluor II metal halide light source (89 North), a Lambda 10-3 filter wheel system (Sutter Instruments), and an ORCA-Flash 2.8 camera (Hamamatsu). Micropipettes were pulled from borosilicate glass capillary tubes (Warner Instruments) using a PP-81 puller (Narishige). Fire-polished micropipettes with a tip resistance of 1.5-3 mΩ were used for current-clamp recordings. The pipette filling solution contained: 145 mM KCl, 1 mM MgCl~2~, 0.1 mM CaCl~2~, 1 mM EGTA, and 10 mM HEPES; pH 7.2. Amphotericin B was added to the pipette solution to a final concentration of 120 μg/ml. The extracellular bath solution contained: 138 mM NaCl, 5 mM KCl, 0.5 mM MgCl~2~, 1.5 mM CaCl~2~, and 10 mM HEPES; pH 7.4. After establishing whole-cell configuration in voltage-clamp mode, the membrane potential was clamped at −60 mV and the cell capacitance was obtained by reading the value for input capacitance neutralization directly from the amplifier. To study firing and action potential properties, the amplifier was switched to current-clamp mode. Signals were low-pass filtered at 1 kHz (four-pole Bessel filter) and digitized with a Digidata 1440A (Molecular Devices) at 5 kHz. Command protocols, data acquisition and analysis were controlled by pClamp 10 software (Molecular Devices).

Data analysis {#s3N}
-------------

Based on the presence or absence of spontaneous action potentials during a 5-min period immediately after achieving whole-cell configuration, sensory neurons were classified as silent or spontaneously active. The passive and active electrical properties of DRG neurons were determined in the current-clamp mode. To determine the input resistance, I/V relationships were generated by injecting 400-ms current steps from −75 to 50 pA in steps of 25 pA. The input resistance was calculated from the slope of I/V relationships. For silent neurons, only those that had a resting membrane potential more negative than −40 mV and generated action potentials with a distinct overshoot higher than 0 mV in response to depolarizing current injections were studied. The action potential properties of bladder sensory neurons were examined as previously described ([@B39]; [@B27]). A series of 4-ms rectangular depolarizing current pulses of increasing intensity were injected until an action potential was evoked ([Fig. 5*C*](#F5){ref-type="fig"}). The following active electrical properties were measured for silent bladder sensory neurons: resting membrane potential (a), action potential overshoot above 0 mV (b), action potential duration at 0 mV (c), magnitude of hyperpolarization below the resting membrane potential (d), action potential threshold (e), and rheobase (f; [Fig. 5*C*](#F5){ref-type="fig"}). Action potential rheobase and threshold are defined as the minimum depolarizing current injection necessary to evoke an action potential and the maximum membrane potential depolarization obtained in the absence of an action potential, respectively. To examine firing patterns in bladder sensory neurons, a series of 500-ms depolarizing rectangular current pulses equivalent to 1, 1.5, 2, 2.5, and 3 times the rheobase were injected every 4 s, and the voltage responses were recorded. To generate stimulus response relationships, the number of spikes evoked were counted and plotted against the corresponding injected current (1, 1.5, 2, 2.5, and 3 times rheobase).

Statistical analysis {#s3O}
--------------------

Data are expressed as mean ± SEM (*n*), where *n* equals the number of independent experiments. Parametric or nonparametric tests were employed as appropriate; *p* \< 0.05 was considered statistically significant. Fitting and statistical comparisons were performed with Clampfit (Molecular Device), Sigmaplot 12.5 (Systat Software), or GraphPad 7 (GraphPad Software).

Results {#s4}
=======

Cldn2-induced cystitis {#s4A}
----------------------

Cldn2 is highly expressed in leaky epithelia such as the proximal tubule of the kidney and small intestine, but its expression is negligible in tight epithelia such as the distal nephron, colon, and urinary bladder ([@B108]; [@B3]; [@B107]; [@B58]; [@B70]). Of significance, Cldn2 expression is upregulated in the distal colon of patient with inflammatory bowel disease and in the urinary bladder of patient with IC ([@B65]; [@B108]; [@B95]; [@B85]; [@B84]). We previously showed that the overexpression of Cldn2 in the umbrella cell layer increases the permeability of the paracellular route toward cations, triggers an inflammatory process in the bladder mucosa and lamina propria with lymphocytic infiltration, and increases voiding frequency ([@B70]). In the present study, to induce cystitis, rat urinary bladders were transduced with AdCldn2 using our established methods ([@B70]). The urothelium endogenously expresses low amounts of Cldn2, which localizes along the lateral surfaces and at the TJ region of the umbrella cell layer ([@B70]). As shown in [Figure 1*A*,*C*](#F1){ref-type="fig"}, *in situ* transduction of bladders with AdCldn2 results in the overexpression of Cldn2 in the urothelium that lines the urinary bladder and urethra. The efficiency of transduction using this protocol was \>95% ([Fig. 1*A*](#F1){ref-type="fig"}). Note that the endogenous expression of Cldn2 in the urothelium is barely detectable under basal conditions ([@B70]). In the current study, rats transduced with an AdGFP served as controls ([Fig. 1*B*](#F1){ref-type="fig"}). Consistent with our previous studies ([@B70]), the Tissue electrical resistance (TER) and tissue electrical potential difference (PD) of bladders transduced with AdCldn2 were significantly lower than those from rats transduced with AdGFP ([Fig. 1*D*,*E*](#F1){ref-type="fig"}). In good agreement with our published histologic findings ([@B70]), tissue water content, a measurement of edema, was significantly greater in bladders transduced with AdCldn2 than controls (GFP: 76.4 ± 2.0%, *n* = 6; Cldn2: 82.1 ± 1.3%, *n* = 6; *p* \< 0.05; [Fig. 1*F*](#F1){ref-type="fig"}).

![Overexpression of Cldn2 in the bladder urothelium induces cystitis. ***A***, Cross-sections of urinary bladder and urethra harvested from rats transduced with AdCldn2, fixed with paraformaldehyde, and stained with an antibody against Cldn2 (green) and Rhodamine Phalloidin (red). Note that the expression of Cldn2 is restricted to the umbrella cell layer in the urinary bladder and to the epithelium in the urethra. ***B***, ***C***, Cross-sections of bladders transduced with AdGFP (***A***) or AdCldn2 (***B***), fixed with paraformaldehyde, and stained with an antibody against Cldn2 (green) and Phalloidin Alexa Fluor 647 for actin (red). Arrows indicate TJs and L indicates lumen. ***D***, ***E***, Tissue electrical resistance (TER) and tissue electrical potential difference (PD) for urinary bladders transduced with AdGFP or AdCldn2. Urinary bladders from transduced rats were mounted in Ussing chambers and the electrical properties were measured as indicated in Materials and Methods. Statistically significant differences between experimental conditions are indicated as \*\*\**p* \< 0.001 (*n* = 6--9, Mann-Whitney nonparametric test). ***F***, Tissue water content of urinary bladders transduced with AdGFP or AdCldn2. A statistically significant difference between experimental conditions is indicated as \**p* \< 0.05 (*n* = 6, Mann-Whitney nonparametric test).](enu0031723180001){#F1}

Overexpression of Cldn2 in the urothelium induces mechanical allodynia in the pelvic region {#s4B}
-------------------------------------------------------------------------------------------

The presence of recurring discomfort and pain in the bladder and the surrounding pelvic region is a hallmark of IC/BPS. To determine whether the overexpression of Cldn2 in the urothelium alters somatic sensitivity in the pelvic area, we measured 50% mechanical withdrawal threshold (g) to von Frey filaments in rats transduced with AdCldn2 or AdGFP. Consistent with the presence of bladder-derived pain and an IC/BPS phenotype, rats transduced with AdCldn2 showed hypersensitivity (lower withdrawal threshold) to von Frey filaments applied to the pelvic region ([Fig. 2*A*](#F2){ref-type="fig"}), but not to the hind paw ([Fig. 2*B*](#F2){ref-type="fig"}). The 50% withdrawal threshold to mechanical stimuli applied to the pelvic region was 0.24 ± 0.13 g (*n* = 7) for rats transduced with AdCldn2 and 2.89 ± 1.07 g (*n* = 7, *p* \< 0.01) for controls transduced with AdGFP. IC/BPS patients have a higher prevalence of irritable bowel symptoms than the general population ([@B1]; [@B49]; [@B12]). To determine whether the overexpression of Cldn2 in the urothelium alters bowel function, we measured fecal pellet output as an index of intestinal motility ([@B6]). Significantly, the number of fecal pellets collected from rats transduced with AdCldn2 was larger than the number collected from rats transduced with AdGFP ([Fig. 2*C*](#F2){ref-type="fig"}). Together, our results indicate that increased urothelial TJ permeability reduces the threshold to mechanical stimuli in the lower abdominal area and adversely alters bowel activity.

![Overexpression of Cldn2 in the urothelium induces pelvic mechanical allodynia and organ cross-sensitization. ***A***, ***B***, Urothelial overexpression of Cldn2 reduces the threshold to mechanical stimuli applied to the pelvic area. Mechanical allodynia on the lower abdominal area close to the urinary bladder (***A***) and on the plantar surface of the hind paw (***B***) was evaluated with von Frey filaments in rats transduced with AdGFP or AdCldn2. 50% mechanical withdrawal threshold (g) was estimated with von Frey filaments applied in an up-down testing paradigm as previously described ([@B17]). Statistically significant difference between experimental conditions is indicated as \*\**p* \< 0.01 (*n* = 7, Mann-Whitney nonparametric test). ***C***, Urothelial overexpression of Cldn2 sensitizes colon afferents. Number of fecal pellets in a 4 h period in rats transduced with AdGFP or AdCldn2. Statistically significant difference between experimental conditions is indicated as \*\**p* \< 0.01 (*n* = 7, Mann-Whitney nonparametric test).](enu0031723180002){#F2}

Overexpression of Cldn2 in the urothelium activates nociceptive pathways in spinal cord segments receiving bladder input {#s4C}
------------------------------------------------------------------------------------------------------------------------

To determine whether increased urothelial TJ permeability activates nociceptive pathways in the spinal cord, we examined the expression of c-Fos and activation of ERK1/2 (phosphorylation) in segments receiving bladder input from rats transduced with AdGFP or AdCldn2. Under physiologic conditions, c-Fos is not expressed in the spinal cord and ERK1/2 activity is low ([@B20]; [@B38]). Previous studies showed that noxious and mechanical stimulation of the lower urinary tract markedly increases c-Fos expression in dorsal horn neurons of the L6-S1 spinal cord ([@B11]; [@B21]; [@B93],). To assess the specificity of the antibody and optimize the immunocytochemical reaction, we examined the expression of c-Fos in rats infused with 1% acetic acid in saline for 2 h. Consistent with previous studies, chemical irritation of the urinary bladder induced the expression of c-Fos in the posterior horn of the L6-S1 spinal cord ([Fig. 3*A*](#F3){ref-type="fig"}), but not L4 (data not shown). c-Fos-positive cells were distributed as previously described throughout the medial dorsal horn, dorsal commissure and sacral parasympathetic nucleus ([@B11]).

![Overexpression of Cldn2 in the urothelium increases the number of c-Fos-immunoreactive cells in spinal cord segments receiving bladder input. ***A***, Micrography of an L6-S1 spinal cord section from a rat infused with 1% acetic acid for 2 h showing the distribution of c-Fos-positive neurons in the dorsal horn (DH). Immunoreactive neurons were distributed throughout the medial DH, dorsal commissure, and sacral parasympathetic nucleus. Arrows indicate areas with c-Fos-positive cells. ***B***, Time course of expression of Cldn2 following *in situ* transduction with AdCldn2. Urothelial samples were collected 6, 12, and 18 h after *in situ* transduction. Nontransduced rats served as controls for this experiment (time 0 h). Whole-cell lysates were subjected to immunoblot with an anti-Cldn2 antibody or an anti-actin antibody. ***C***, Micrography of an L6-S1 spinal cord section from a rat transduced with AdGFP. ***D***, Micrography of an L6-S1 spinal cord section from a rat transduced with AdCldn2. Arrows indicate areas with c-Fos-positive cells. c-Fos-positive cells were distributed throughout the medial DH, dorsal commissure, and sacral parasympathetic nucleus. ***E***, Number of c-Fos-positive neurons per section in spinal cord segments from rats transduced with AdGFP and AdCldn2. Statistically significant differences between experimental conditions are indicated as \**p* \< 0.05 and \*\**p* \< 0.01 (*n* = 7, Mann-Whitney nonparametric test).](enu0031723180003){#F3}

Following acute chemical irritation of the lower urinary tract with acetic acid, c-Fos expression in LS (L6-S1) spinal cord segments peaks 1--2 h after the initial expo-sure, begins to decline at 6 h and returns to basal levels 24 h after exposure ([@B11]). If increased urothelial permeability causes noxious stimulation of bladder afferents, then c-Fos expression should increase along with the expression of Cldn2. To determine the time course of Cldn2 expression in the urothelium following *in situ* transduction, we performed Western blot analysis with urothelial samples collected 6, 12, and 18 h after transduction. Nontransduced rats serve as controls for this experiment (time 0). As shown in [Figure 3*B*](#F3){ref-type="fig"}, the expression of Cldn2 reaches to a peak 12 h after transduction. Therefore, c-Fos expression in spinal cord segments receiving afferent input from the pelvic (L6-S1) and hypogastric (T13-L2) nerves was examined 12 h after transduction. Consistent with previous studies, c-Fos-positive cells were distributed in the dorsal horn areas that receive bladder afferent input: medial dorsal horn, dorsal commissure, and sacral parasympathetic nucleus ([Fig. 3*D*](#F3){ref-type="fig"}). The number of c-Fos-positive cells in spinal cord segments receiving afferent input from the pelvic (L6-S1) nerve from rats transduced with AdCldn2 was significantly larger than in those transduced with AdGFP ([Fig. 3*E*](#F3){ref-type="fig"}). No statistically significant differences in the number of c-Fos-positive cells in C4 and T13-L2 spinal cord segments were observed between rats transduced with AdGFP and AdCldn2. Unexpectedly, the number of c-Fos-positive cells in L4 segments was significantly larger in rats transduced with AdCldn2 than AdGFP ([Fig. 3*E*](#F3){ref-type="fig"}). These results suggest that increased urothelial permeability activates nociceptive pathways in the spinal cord.

ERK1/2 is rapidly activated (phosphorylated) in the spinal cord dorsal horn following noxious peripheral stimulation and its expression correlates well with pain behavior assessments in experimental animals ([@B53]; [@B91]; [@B23]; [@B52]; [@B74]; [@B19]; [@B38]; [@B62]; [@B61]; [@B83]; [@B30]). To determine whether increased urothelial permeability activates the ERK pathway in spinal cord segments receiving bladder afferent input, we performed Western blot analysis of total (ERK) and the phosphorylated forms of ERK1/2 (pERK) 24 h after transduction with AdGFP or AdCldn2 ([Fig. 4](#F4){ref-type="fig"}). Consistent with the notion that increased urothelial TJ permeability activates nociceptive pathways, we observed a significant increase in pERK/ERK ratio in spinal cord segments receiving bladder input from the hypogastric (TL) and pelvic (LS) nerves of animals transduced with AdCldn2, when compared with controls ([Fig. 4*B*](#F4){ref-type="fig"}). Taken as a whole, our studies show that reduced urothelial TJ barrier function promotes noxious stimulation of bladder afferent pathways.

![Overexpression of Cldn2 in the urothelium activates ERK in spinal cord segments receiving bladder input. ***A***, Representative Western blotting of total (ERK) and phosphorylated (pERK) forms of ERK1/2 in spinal cord segments receiving pelvic (LS) and hypogastric (TL) nerve afferents from rats transduced with AdGFP or AdCldn2. ***B***, Analysis of pERK/ERK ratio in LS and TL segments of rats transduced with AdGFP or AdCldn2. Statistically significant differences between experimental conditions are indicated as \**p* \< 0.05 and \*\**p* \< 0.01 (*n* = 10--11, Mann-Whitney nonparametric test).](enu0031723180004){#F4}

Overexpression of Cldn2 in the urothelium promotes spontaneous firing of bladder afferent neurons {#s4D}
-------------------------------------------------------------------------------------------------

To determine whether the mechanical allodynia observed in rats overexpressing Cldn2 in the urothelium results from altered afferent activity, we conducted patch-clamp studies with acutely isolated bladder sensory neurons harvested from rats transduced with AdGFP or AdCldn2. To label bladder afferents, DiI was injected into the bladder wall. The dye is transported in a retrograde fashion and reaches somas in LS (L6-S2) and TL (T13-L2) DRG one to two weeks after injection. [Figure 5*A*](#F5){ref-type="fig"} shows DIC and epifluorescence micrographs from a lumbar 1 (L1) DRG harvested from a rat injected with DiI into the bladder wall. Bright-field and epifluorescence micrographs of acutely isolated LS (L6-S2) DRG neurons from a rat injected with DiI are shown in [Figure 5*B*](#F5){ref-type="fig"}. The activity and electrical properties of acutely isolated bladder sensory neurons were examined with the perforated patch-clamp technique in the current-clamp mode ([Fig. 5*C*](#F5){ref-type="fig"}). The amphotericin B-perforated patch-clamp technique has the advantage of maintaining the cytosolic composition without altering endogenous levels of Ca^2+^ and signaling molecules. Previous patch-clamp studies performed with retrogradely labeled bladder neurons described two general populations, one with tetrodotoxin-resistant (TTX-R) action potentials and another with TTX-sensitive (TTX-S) action potentials ([@B103]). The population of neurons with TTX-R action potentials is sensitive to capsaicin and is likely to be of C-fiber origin ([@B101]). Most Aδ fiber afferent neurons exhibit TTX-S action potentials and are insensitive to capsaicin ([@B28]). In the present study, we classified the action potentials of bladder sensory neurons as TTX-S or TTX-R. Representative recordings of bladder sensory neurons with TTX-S and TTX-R action potentials are shown in [Figure 5*D*,*E*](#F5){ref-type="fig"}. In controls (AdGFP-transduced) rats, a similar proportion of LS (61%, 36/59) and TL (55%, 29/53) bladder sensory neurons exhibited TTX-R action potentials ([Fig. 6*A*](#F6){ref-type="fig"}). The whole-cell membrane capacitance of the neurons harvested from rats transduced with AdGFP with TTX-R action potentials was similar to the neurons with TTX-S action potentials ([Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). Whereas bladder afferent neurons harvested from rats transduced with AdGFP were electrically silent (LS, 0/59; TL, 0/53), ∼30% (LS, 20/67; TL, 15/54) of the bladder afferents from rats transduced with AdCldn2 exhibited spontaneous action potentials ([Fig. 6*A*](#F6){ref-type="fig"}). Of the LS bladder sensory neurons with spontaneous activity, 50% (10/20) exhibited TTX-S action potentials ([Fig. 6*A*](#F6){ref-type="fig"}). Among the TL bladder sensory neurons with spontaneous activity, the majority exhibited TTX-S action potentials (11 of 15). The whole-cell membrane capacitance of bladder sensory neurons harvested from rats transduced with AdCldn2 with spontaneous activity (32.8 ± 2.1 pF, *n* = 33) did not differ from that of silent neurons (30.0 ± 1.1 pF, *n* = 85, *p* = 0.24, unpaired *t* test with Welch's correction). For the most part, whole-cell membrane capacitance and input resistance of silent bladder sensory neurons harvested from rats transduced with GFP were of similar magnitude to those from neurons harvested from rats transduced with Cldn2 ([Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). In contrast to the overall increase in cell size reported in sensory neurons from rats treated with cyclosphosphamide ([@B101]; [@B26]), our results indicate that increased urothelial TJ barrier permeability does not alter the cell size distribution of the bladder sensory neurons. Spontaneously active neurons exhibited lower resting membrane potentials than silent neurons and irregular membrane potential oscillations ([Fig. 6*C*,*D*](#F6){ref-type="fig"}). The membrane potential mean and oscillation amplitude for the LS bladder sensory neurons with spontaneous activity were −43.2 ± 1.9 mV ([Fig. 6*C*](#F6){ref-type="fig"}) and 9.4 ± 0.7 mV (data not shown), and for the TL bladder sensory neurons with spontaneous activity were −46.7 ± 2.0 mV ([Fig. 6*D*](#F6){ref-type="fig"}) and 9.8 ± 1.0 mV (data not shown), respectively.

![Analysis of electrical properties of bladder sensory neurons. DRGs were harvested from rats injected with DiI into the bladder wall. ***A***, DIC and epifluorescence micrographies captured from a cryosection of a paraformaldehyde fixed DRG (L1). ***B***, Bright field and epifluorescence micrographies of acutely isolated LS (L6-S2) DRG neurons captured during a patch-clamp experiment. ***C***, Analysis of passive and active action potential properties. Representative voltage trace registered in the current-clamp mode with the perforated patch-clamp technique from a Dil-labeled bladder sensory neuron. Action potentials were evoked by 4-ms depolarizing current pulses through the recording electrode. The current injection protocol is shown beneath voltage trace. Letters refer to properties of the action potential examined. a, resting membrane potential; b, action potential overshoot (above 0 mV); c, action potential duration at 0 mV; d, magnitude of after hyperpolarization (AHP) below resting membrane potential (in mV); e, action potential threshold, which is defined as the greatest membrane potential (mV) achieved in response to a current pulse that does not trigger an action potential; f, rheobase, which is defined as the smallest amount of depolarizing current (pA) required to trigger an action potential. ***D***, ***E***, Classification of DiI-labeled bladder neurons on the basis of the sensitivity of the action potential to TTX. Representative tracing of DiI-labeled bladder neurons with TTX-R (***D***) and TTX-S (***E***) action potentials.](enu0031723180005){#F5}

![Overexpression of Cldn2 in the urothelium induces spontaneous activity in both LS and TL bladder sensory neurons. LS (L6-S2) and TL (T13-L2) DRGs were harvested from rats 9--13 d after injection of DiI in the bladder wall. The day before DRG collection, rats were transduced with AdGFP or AdCldn2. DRG neurons were isolated and cultured as indicated in Materials and Methods. Action potential activity in acutely isolated bladder sensory neurons was examined with the perforated patch-clamp technique. Sensory neurons were classified on the basis of their origin (LS or TL) and sensitivity of the action potential to 1 μM TTX (TTX-S or TTX-R). ***A***, Proportion of silent and spontaneously active (SA) LS and TL neurons from rats transduced with AdGFP or AdCldn2. Neither LS nor TL bladder DRG neurons were spontaneously active in rats transduced with GFP (0/112). Approximately 30% (LS, 20/67 and TL, 15/54) of the neurons harvested from rats transduced with AdCldn2 showed spontaneous activity. Of the bladder neurons with spontaneous activity harvested from rats transduced with AdCldn2, 15% (10/67) of the LS sensory neurons exhibited TTX-S action potentials, while 20% (11/54) of the TL sensory neurons exhibited TTX-S action potentials. Data were collected from 12 rats transduced with AdGFP and 12 rats transduced with AdCldn2. ***B***, Representative voltage tracings from bladder sensory neurons harvested from rats transduced with AdCldn2 with spontaneous TTX-S (upper panel) or TTX-R (lower panel) action potentials. ***C***, Resting membrane potential of LS bladder sensory neurons. Statistically significant differences between neurons with spontaneous action potentials and their TTX-S or TTX-R silent counterparts are indicated as \**p* \< 0.05 and +*p* \< 0.001 (*n* = 10--36, Kruskal-Wallis test followed Dunn\'s multiple comparisons test). ***D***, Resting membrane potential of TL bladder sensory neurons. Statistically significant differences between neurons with spontaneous action potentials and their TTX-S or TTX-R silent counterparts are indicated as \*\**p* \< 0.01 and +*p* \< 0.001 (*n* = 4--29, Kruskal-Wallis test followed Dunn\'s multiple comparisons test).](enu0031723180006){#F6}

###### 

Passive and active electrical properties of LS bladder sensory neurons from rats transduced with AdGFP or AdCldn2

  --------------------------------------------------------------------------------------------------------------
                      GFP           Cldn2                                                          
  ------------------- ------------- ------------- ------------------------------------------------ -------------
  Number of cells\    *n* = 23\     *n* = 36\     *n* = 18\                                        *n* = 29\
  RMP (mV)            −64.8 ± 1.1   −63.6 ± 0.9   −57.9 ± 1.6[\*\*](#TF1){ref-type="table-fn"}     −62.1 ± 1.1

  C~m~ (pF)           30.8 ± 2.6    29.7 ± 1.8    30.1 ± 2.5                                       29.1 ± 1.3

  R~In~ (GΩ)          0.88 ± 0.08   1.15 ± 0.09   0.83 ± 0.10                                      1.04 ± 0.08

  AP threshold (mV)   −29.1 ± 0.7   −22.2 ± 0.5   −34.2 ± 0.7[\*\*\*](#TF1){ref-type="table-fn"}   −23.8 ± 0.8

  AP duration (ms)    3.5 ± 0.2     6.3 ± 0.4     4.1 ± 0.5                                        5.9 ± 0.7

  AP overshoot (mV)   32.0 ± 2.8    38.0 ± 2.7    30.5 ± 3.7                                       40.0 ± 2.5

  Rheobase (pA)       300 ± 45      393 ± 34      159 ± 38[\*](#TF1){ref-type="table-fn"}          361 ± 45

  AHP mag (mV)        −10.8 ± 1.2   −10.1 ± 0.8   −12.1 ± 1.6                                      −10.3 ± 0.6
  --------------------------------------------------------------------------------------------------------------

Values are means ± SEM. Statistically significant differences compared with control (GFP) are indicated as \**p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001 (unpaired *t* test with Welch's correction). RMP, resting membrane potential; C~m~, membrane capacitance; R~In~, input resistance; AP, action potential; AHP mag, magnitude of hyperpolarization below the resting membrane potential.

###### 

Passive and active electrical properties of TL bladder sensory neurons from rats transduced with AdGFP or AdCldn2

                      GFP           Cldn2                                                          
  ------------------- ------------- ------------- ------------------------------------------------ -------------------------------------------
  C~m~ (pF)           35.3 ± 2.7    32.5 ± 1.9    37.2 ± 3.8                                       26.7 ± 2.1[\*](#TF2){ref-type="table-fn"}
  R~In~ (GΩ)          0.65 ± 0.10   0.81 ± 0.10   0.67 ± 0.08                                      1.00 ± 0.09
  AP threshold (mV)   −26.6 ± 0.8   −20.4 ± 0.9   −31.3 ± 0.7[\*\*\*](#TF2){ref-type="table-fn"}   −21.1 ± 0.5
  AP duration (ms)    3.3 ± 0.3     4.3 ± 0.3     3.6 ± 0.4                                        3.6 ± 0.3
  AP overshoot (mV)   34.5 ± 2.8    33.1 ± 2.3    24.2 ± 2.5[\*\*](#TF2){ref-type="table-fn"}      35.0 ± 1.9
  Rheobase (pA)       500 ± 90      393 ± 55      384 ± 82                                         511 ± 52
  AHP mag (mV)        −14.3 ± 1.6   −13.5 ± 1.6   −11.6 ± 1.4                                      −13.6 ± 2.1

Values are means ± SEM. Statistically significant differences compared with control (GFP) are indicated as \**p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001 (unpaired *t* test with Welch's correction). RMP, resting membrane potential; C~m~, membrane capacitance; R~In~, input resistance; AP, action potential; AHP mag, magnitude of hyperpolarization below the resting membrane potential.

Overexpression of Cldn2 in the urothelium sensitizes TTX-S bladder sensory neurons {#s4E}
----------------------------------------------------------------------------------

To assess whether the overexpression of Cldn2 in the urothelium alters the excitability of bladder afferents, we examined the passive and active electrical properties of silent bladder sensory neurons harvested from rats transduced with AdGFP or AdCldn2. Consistent with previous studies ([@B103]), bladder afferent neurons with TTX-R action potentials harvested from rats transduced with AdGFP (control) exhibited action potentials with higher threshold than the counterparts with TTX-S action potentials ([Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). The overexpression of Cldn2 in the urothelium did not change the active or passive membrane properties of LS or TL bladder sensory neurons with TTX-R action potentials ([Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). However, LS neurons with TTX-S action potentials from rats transduced with AdCldn2 have lower resting membrane potential, action potential threshold and rheobase than counterparts from rats transduced with AdGFP ([Table 1](#T1){ref-type="table"}). Similarly, we observed lower action potential threshold and action potential overshoot in TL sensory neurons with TTX-S action potentials harvested from rats transduced with AdCldn2 than control counterparts ([Table 2](#T2){ref-type="table"}). Taken together, our results indicate that increased urothelial TJ barrier permeability alters the passive and active electrical properties of the bladder sensory neurons with TTX-S action potentials. Because hypogastric and pelvic afferents mediate divergent functions ([@B27]), it is not surprising that increased urothelial TJ barrier permeability affects different passive and active electrical properties in LS and TL bladder sensory neurons.

Finally, to examine the excitability of LS bladder sensory neurons in response to electrical stimulation, we injected suprathreshold current pulses equivalent to 1, 1.5, 2, 2.5, and 3 times the rheobase for 500 ms with 4-s intervals. Consistent with previous studies ([@B101]; [@B105]; [@B27]), sensory neurons harvested from rats transduced with AdGFP exhibited a phasic pattern of action potential firing in response to suprathreshold stimuli ([Fig. 7*A*,*B*](#F7){ref-type="fig"}). No significant differences in the firing were observed among TTX-R neurons harvested from rats transduced with AdCldn2 or AdGFP ([Fig. 7*C*](#F7){ref-type="fig"}, LS, *D*, TL). However, suprathreshold stimuli evoked a significantly greater number of spikes in bladder sensory neurons with TTX-S action potentials from rats transduced with AdCldn2 than in control counterparts ([Fig. 7](#F7){ref-type="fig"}). Taken together, our studies indicate that increased TJ permeability sensitizes bladder sensory neurons with TTX-S action potentials, and that this process contributes to the bladder hyperreflexia and pelvic pain observed in rats transduced with AdCldn2.

![Overexpression of Cldn2 in the urothelium sensitizes LS and TL bladder sensory neurons with TTX-S action potentials. LS (L6-S2) and TL (T13-L2) DRGs were harvested from rats transduced with AdGFP or AdCldn2. The response of sensory neurons to suprathreshold stimulation was examined with the perforated patch-clamp technique. ***A***, ***B***, Representative tracings of action potential firing pattern in response to suprathreshold stimulation for LS (***A***) and TL (***B***) bladder DRG neurons with TTX-S action potentials. Action potentials were evoked by the injection of 500-ms depolarizing current pulses \[1, 1.5, 2, 2.5, and 3 times (X) the rheobase\] through the patch pipette. Current pulse protocols are shown at the bottom of the panels. ***C***, ***D***, Stimulus response relationships for LS (***C***) and TL (***D***) bladder sensory neurons. Action potentials were evoked by the injection of depolarizing current pulses as indicated above. The number of spikes evoked in response to stimuli of increased intensity for each neuron were computed. Sensory neurons were classified on the basis of their origin and the sensitivity of the action potential to 1 μM TTX. Statistically significant differences between neurons with TTX-S action potentials from rats transduced with AdCldn2 and control TTX-S counterparts are indicated as, \**p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001 (*n* = 15--36, Mann-Whitney nonparametric test).](enu0031723180007){#F7}

Discussion {#s5}
==========

Urothelial barrier function depends on the presence of high resistance TJs ([@B54]), which not only regulate paracellular permeability, but may also play a role in the sensory function of the urothelium ([@B15]). despite the prevalence of IC/BPS (\>4,000,000 affected individuals in the United States), its etiology remains unknown. Animal models have provided limited insight into the pathophysiology of this disease, particularly with regard to the mechanisms that drive pelvic pain in IC/BPS patients. Most of the models of IC/BPS test the impact of extrinsic factors and insults but do not explore intrinsic defects that are known to be associated with IC/BPS (e.g., increased expression of Cldn2 message). Although irritants and immune stimulants increase urinary frequency, they fail to reproduce the localized abdominal pain present in IC/BPS patients ([@B57]). For instance, mice treated with the alkylating agent cyclophosphamide present generalized increased sensitivity to mechanical stimuli ([@B89]; [@B68]). Likewise, models of experimental autoimmune cystitis exhibit increased pain response to noxious stimulation in the pelvic area as well as the hind paw ([@B9]). Consistent with the presence of bladder-derived pain, rats overexpressing Cldn2 in the urothelium showed hypersensitivity to von Frey filaments applied to the pelvic region, but not to the hind paw. The reduction of the withdrawal threshold to von Frey filaments observed in rats transduced with AdCldn2 is more likely the result of noxious stimulation of the afferent pathways. In support of this notion, we noticed an increase in the expression of c-Fos and activation of ERK1/2 in spinal cord segments receiving bladder input. Unexpectedly, c-Fos expression was increased in L4 segments of rats transduced with AdCldn2 when compared with controls. Since bladder afferents from the urinary bladder project to discrete regions of the L6-S1 and T13-L2 spinal cord ([@B102]; [@B28]; [@B29]), we posit that the observed increase in the expression of c-Fos in L4 segments of rats transduced with AdCldn2 results from the activation of ascending pathways, or from biting/scratching behavior as a response to visceral pain and irritation. Together, our studies indicate that the model of cystitis induced by the overexpression of Cldn2 in the urothelium resembles the symptoms and histologic features of human IC/BPS, particularly the bladder-derived pelvic pain.

Sustained increase in spontaneous afferent activity has a well-established role in ongoing pain ([@B32]; [@B100]) and has been shown to be one of the immediate events after peripheral nerve damage ([@B13]; [@B90]; [@B99]), spinal cord injury ([@B8]; [@B100]; [@B7]), and tissue inflammation ([@B56]; [@B32]; [@B98]). Spontaneous activity of primary sensory neurons can induce and maintain central sensitization ([@B51]; [@B99]), while pharmacological blockade of spontaneous afferent activity immediately after peripheral nerve injury has been shown to permanently reduce or eliminate spontaneous pain, thermal and mechanical hyperalgesia ([@B97]; [@B63]; [@B18]; [@B99]). Dang and colleagues reported that 35% of the LS and 45% of the TL bladder sensory neurons from rats treated chronically with cyclophosphamide, but not controls, exhibit spontaneous activity ([@B27]). Our studies shown that ∼30% of LS and TL bladder sensory neurons harvested from rats transduced with AdCldn2, but not with AdGFP, exhibit spontaneous activity. We found that bladder sensory neurons with TTX-S action potentials harvested from animals transduced with AdCldn2 exhibited increased response to suprathreshold stimulation as well as marked differences with respect to the passive and active electrical properties, when compared with neurons harvested from rats transduced with AdGFP. Together, these results support the notion that in the face of a leaky urothelium, spontaneous activity and sensitization of afferents causes bladder hyperreflexia and drives pelvic pain.

The urine contains large amounts of small solutes, such as K^+^ (120--475 mM) and NH~4~ ^+^ (10.4--56.2 mM; [@B87]), that can potentially permeate through the TJs and alter neuronal excitability and activity. Because overexpression of Cldn2 increases the permeability of the urothelium to small ions, without altering the barrier to large organic molecules ([@B70]), we posit that afferent sensitization is prompted by urinary solutes that diffuse through TJs and accumulate in the bladder interstitium. Since even small changes in extracellular \[K^+^\] can exert profound effects on neuronal excitability, smooth muscle function, and inflammatory cell activation ([@B48]; [@B22]; [@B92]; [@B80]; [@B76]; [@B60]; [@B67]; [@B2]; [@B69]), we speculate that urinary K^+^ contributes to the bladder hyperreflexia and pain observed in rats transduced with Cldn2. Although the overexpression of Cldn2 in umbrella cells does not affect the structural integrity of the umbrella cell layer, it generates an inflammatory response in the urinary bladder characterized by the presence of a lymphocytic infiltrate and edema ([@B70]). Consequently, we cannot rule out that the inflammatory process triggered by the overexpression of Cldn2 in the urothelium contributes to some degree to the sensitization of bladder afferents.

The general consensus is that normal micturition depends on mechanosensitive Aδ fiber afferents that respond to bladder distention in the physiologic range ([@B36]; [@B28]). The role of C fibers on bladder function is less clear. Initial reports indicate that bladder C fibers have high thresholds and respond to bladder distention only at elevated pressure ([@B50]; [@B5]; [@B43]). However, this notion was challenged by reports describing a subpopulation of bladder C fiber afferents that respond to bladder distention in the physiologic range of pressures ([@B34]; [@B4]; [@B86]; [@B96]; [@B33]). As with other afferents innervating hollow organ structures, a key feature of bladder afferent neurons is that they become sensitized after organ insult and in chronic pathologic conditions such as tissue inflammation or irritation ([@B27]; [@B26]; [@B106]). Previous studies showed that chronic cyclophosphamide administration sensitizes mainly fibers of C origin ([@B64]; [@B101]; [@B104]; [@B47]). In contrast, our studies indicate that the overexpression of Cldn2 in the urothelium increases the excitability of bladder afferent with TTX-S action potential, which are considered of Aδ origin ([@B101]). We posit that this discrepancy reflects differences in the underlying mechanisms that lead to cystitis in rats treated with cyclophosphamide and those overexpressing Cldn2. We cannot rule out that during the course of experimental cystitis different afferent pathways are sensitized at early and late time points.

Several lines of research support the notion that Aδ bladder afferents contribute to lower urinary tract symptoms and pain in IC/BPS patients and cats with feline IC, a naturally occurring form of IC that presents with reduced urothelial barrier function. For instance, Aδ bladder afferents from cats with feline IC show greater sensitivity to pressure than those from normal cats ([@B82]). Moreover, clinical studies showed that capsaicin and resiniferatoxin, two substances that target C fibers, are ineffective in the treatment of IC/BPS symptoms ([@B42]; [@B35]). The present results indicate that increased urothelial TJ permeability augments the electrical excitability of bladder sensory neurons primarily of Aδ origin, which promotes voiding at low filling volumes and lowers pelvic pain threshold to mechanical stimuli. In summary, our manuscript presents critical new insights into the mechanisms by which urothelial TJ barrier dysfunction causes bladder hyperreflexia and pain, providing a rational foundation to treat IC/BPS.
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Synthesis {#s6}
=========

Reviewing Editor: Kirill Martemyanov, The Scripps Research Institute

Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below.

Synthesis.

Both reviewers agreed that results presented in the manuscript are potentially important and are of interest to neuro-urology field and understanding mechanisms of visceral pain initiation. The molecular link established in this study was deemed important and in general the reviewers were satisfied with the responses to their initial comments. However, the reviewers also identified several areas of lingering concerns and it was felt that these issues need to be addressed to increase confidence in the interpretation of the results and enhance impact of the report.

Specifically I would like to direct your attention to the following areas that will be critical for you to address upon revision of your manuscript.

1\. The common area of concern identified by both reviewers pertains to the pERK studies. As reviewers suggest, ERK phosphorylation needs to be studied at nearby spinal sites as a control. The low levels of basal phosphorylation warrants exploring other antibodies for IHC and/or consider applying noxious stimulation (See references Ji et al, 2002 Nature Neuroscience; Cruz et al 2005 Eur J. Neuroscience for guidance) to increase the levels. Perhaps more representative blots could be chosen and the data need to be shown as a scatter-plot. Please refer to unedited comments below for additional details.

2\. It would be very helpful to provide experimental evidence for the relevance of Cldn2 expression changes to pathological conditions. Please consider examining changes in Cldn2 expression either in BPS/IC patient tissues or relevant animal models of the disease.

3\. It would be important to demonstrate the extent of the claudin over-expression across the bladder and proximal urethra. This would also benefit researchers who wish to use this manipulation in the future, especially to check that their over-expression is comparable. Please provide additional images to demonstrate this - e.g. lower magnification images that show a larger area of urothelium. Your response letter claims to have provided this but the reviewers find this not to be the case reporting that instead you provided a slightly larger image at a very similar magnification to the others, so the reader still has no further information to assess how consistently or broadly across the bladder surface the urothelium expression levels were altered. This should be a very easy image (or set of images) to generate.

4\. Please elaborate the description on urethra clip procedure along the lines stated in the rebuttal letter to ensure compliance with ethical treatment of animal subjects.

5\. It would be important to incorporate suggestions provided by reviewer \#2 and address the concerns of this reviewer as detailed below.

For your reference, I am providing unedited comments provided by both reviewers below. I hope you find them helpful for improving your manuscript.

Specific Reviewer\'s Comments

Reviewer \#1

This is an interesting study that adds to a complex area of research. Indeed, after so many years of clinical and fundamental research, the full pathophysiological mechanisms of BPS/IC remain to be fully elucidated. This study shows that by upregulating the expression of a single junctional protein rats present signs of pain and increased neuronal firing, two features present in both animal models of disease and BPS/IC patients. Although the authors refer that Cldn2 is upregulated in patients (and they refer to a clinical study), the truth is that study only demonstrated increased mRNA and not the protein, which do not always go hand in hand. Although the models of BPS/IC are not ideal and have a strong inflammatory component, I would suggest the authors to test the expression of Cldn2 in pathological conditions and, ideally, in bladder biopsies. As is, we do not know if the genetically driven Cldn2 overexpression is comparable to what is seen in pathological conditions.

Another point relates to pERK. The bands shown are barely visible and were only demonstrated in thoracic regions. In addition, as far as I understood, these are basal levels of activation. I wonder how much higher pERK levels induced by stimulation (eg, bladder stimulation) would be in transduced animals. I also missed immunohistochemistry analysis of spinal samples as pERK posive cells could be glial or neuronal cells, the location of which could having different meanings (eg, laminae I-I versus laminae IX and X). In addition, I would like to see bands also from the lumbar region (L5-L6) and, as a control, from high thoracic or cervical cord.

Reviewer \#2

The authors have provided extensive discussion of the issues raised. While some issues were addressed satisfactorily in the rebuttal and revised manuscript, I was unable to find changes in areas directly related to several of my comments. My comments here are numbered to match those in the authors\' rebuttal.

1\.

a\. Although the additional experiments could be challenging (e.g., requiring pharmacological or molecular modification of the inflammatory response), I do not agree that "there is no means to determine the contribution of the inflammation to the observed neural changes". If additional experiments are not conducted, I suggest revising the relevant section of the Discussion to expand upon this current limitation, such as describing how this may be addressed in the future and how mechanistic hypotheses could look, if this causal relationship does or does not exist.

b\. To clarify, I did not state or intend to infer that "any type of inflammatory processes impact bladder afferents in a similar manner".

2\. The additional image provided (new panel A) has very little difference in magnification than others in the original panel. The image is larger, but the calibration bars and the cell/nuclear sizes in A show that the magnification is very similar to the other panels. As such, the image provides only slightly more information than the other panels, providing a view of the suburothelial expression level in a very small region of bladder. My original suggestion to demonstrate the expression at lower magnification would have had the benefit of showing how consistent or otherwise the urothelium was transfected around the circumference of a bladder section and in different regions of the lower urinary tract (e.g. if the bladder neck and proximal urethra were also transfected). This information has still not been provided, in images or in the text; I was also unable to find this information in the 2015 AJP paper.

3\. It is possible that the authors have misunderstood the meaning of my comment that referred to the difficulty in (ie limitations of) using the results from longer treatment periods (as published by other groups, for different cystitis models) to interpret the results from this 24h treatment period. I did not question the choice of experimental time point. I also did not suggest extrapolating from their data to published data from CYP studies. Quite the opposite - I still consider that the Discussion would benefit from making it clearer to the reader what limitations there may be in making inferences from studies with quite different treatment periods. Many of these studies are referred to in the Discussion. My reference to Dang et al was simply an example of a study that was cited but with a different post-treatment period.

4\. There was no response to my proposal of strengthening the experiment by measuring ERK phosphorylation at other nearby spinal levels. It is useful to know that attempts were made to visualize ERK phosphorylation in spinal cords from these treated animals. It is surprising that they were unable to visualise ERK phosphorylation in rat cord, with either stimulus. I do not consider this an essential experiment but it would have greatly enhanced the work, especially because of the inherent limitations of Western blotting and its quantitation. The faint increase in signal from samples 1 and 3 is just visible but, if this is the best example from the 10-11 replicates, is still not impressive and raises the question of what was different about sample 2 (an animal more sensitive to the bladder manipulation perhaps?). Given this level of variability, it may be worthwhile to provide the ERK data as a scatter plot as well as a histogram.

5\. The absence of published data to support a change in nerve density (increase due to collateral growth or decrease due to degeneration) is not surprising as, to my knowledge, very few groups (if any) have quantified nerve density at 24 hours after any bladder treatment. I am not aware of this type of anatomical measurement having been performed at this early time point or across bladder inflammation models. Also, as the authors have rightly pointed out, not all bladder inflammation models should be considered as the same, so even if this data did exist for a different model, this would not necessarily infer an absence of effect in this Claudin manipulation study. I don\'t see how the authors can be so confident that there are no changes, given the known rapid ability for plasticity and remodelling of peripheral terminals.

6\. It is pleasing to learn that animals were randomized to blinded treatment and control groups. This should be stated in the Methods. It remains disappointing that estrus cycle stage was not monitored at the time of tissue removal and hope this simple assay is conducted in future studies.

7\. The additional information re the method of urethra clipping is useful and reassuring. This additional information should be included in the manuscript.

8\. The authors are correct - the term "retraction" rather than "contraction" was used. I apologise for this error, but my question is not altered by this - the method is not explained and "retraction" is no clearer. A common assay for assessing visceral pain in distensible organs (eg bladder, rectum) is the visceromotor reflex (VMR), which measures contraction of specific muscle groups. If this is the assay performed, it should be stated and described as such. If the authors are using a different assay (eg of different muscles or if their measurement is simply macroscopic visual assessment rather than measuring muscle activity), this should be explained - ie which particular muscles and the nature of the measurement.

9\. I apologise that I missed that one panel of figure 4 was from fixed tissue.

10\. I accept that the authors did not specifically refer to extrinsic afferent sensitization. My comment was simply a suggestion to assist in interpretation of their observation.

11\. Thank you for clarifying the tracing period duration.
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